Growth hormone peptides and recovery-focused compounds represent one of the most actively researched areas in peptide science. Ipamorelin belongs to this category, with research exploring its potential effects on growth hormone signaling, tissue repair, and recovery processes.
A selective, clean GH secretagogue with minimal effect on cortisol, prolactin, or ACTH. Widely studied for its favorable safety profile in growth hormone stimulation research.
Also Known As
IPA, NNC 26-0161
What is Ipamorelin?
Ipamorelin is classified under the GH / Recovery category of peptides. A selective, clean GH secretagogue with minimal effect on cortisol, prolactin, or ACTH. Widely studied for its favorable safety profile in growth hormone stimulation research.
Mechanism of Action: A selective growth hormone secretagogue that acts on the ghrelin/GHS receptor (GHSR-1a) in the pituitary gland. Unlike other GHRPs, ipamorelin does not significantly affect cortisol, prolactin, or ACTH levels, making it one of the most selective GH secretagogues.
Growth Hormone & Recovery Research
Primary Research Areas: Growth hormone release, body composition, bone density, postoperative ileus, anti-aging research.
Key Research Findings: Studies show dose-dependent GH release without significant cortisol or prolactin elevation. A Phase II trial for postoperative ileus showed promising results in reducing time to first bowel movement after surgery.
Safety Profile & Considerations
Generally well-tolerated in clinical studies. May cause transient headache, flushing, or injection site reactions. Long-term safety data is limited.
Related Research Topics
Understanding Ipamorelin requires familiarity with these related concepts in gh / recovery research. Each topic represents a broader field that intersects with current peptide research.
References & Further Reading
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
Stay Updated on Peptide Research
Get the latest science-backed articles on peptides delivered to your inbox.